Emily Bodnar
Stock Analyst at HC Wainwright & Co.
(0.79)
# 3,651
Out of 4,714 analysts
257
Total ratings
21.93%
Success rate
-25.91%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Emily Bodnar
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IMNN Imunon | Reiterates: Buy | $12 | $1.02 | +1,076.47% | 11 | Dec 19, 2024 | |
| RNAZ TransCode Therapeutics | Maintains: Buy | $3 → $20 | $3.64 | +449.45% | 13 | Dec 18, 2024 | |
| ATOS Atossa Therapeutics | Reiterates: Buy | $7 | $1.01 | +593.07% | 11 | Dec 13, 2024 | |
| BCTX BriaCell Therapeutics | Reiterates: Buy | $15 | $0.64 | +2,241.19% | 12 | Dec 12, 2024 | |
| OLMA Olema Pharmaceuticals | Reiterates: Buy | n/a | $5.89 | - | 16 | Dec 12, 2024 | |
| ANAB AnaptysBio | Downgrades: Neutral | n/a | $14.60 | - | 6 | Dec 11, 2024 | |
| SLRN Acelyrin | Reiterates: Neutral | $8 | $3.82 | +109.42% | 12 | Dec 11, 2024 | |
| ACLX Arcellx | Reiterates: Buy | $115 | $79.13 | +45.33% | 12 | Dec 10, 2024 | |
| GERN Geron | Reiterates: Buy | $9 | $3.57 | +152.10% | 3 | Dec 10, 2024 | |
| AGEN Agenus | Reiterates: Neutral | n/a | $3.27 | - | 12 | Dec 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $12 | $1.12 | +971.43% | 15 | Dec 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $38 | $30.19 | +25.87% | 17 | Dec 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 | $1.71 | +367.84% | 8 | Nov 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $33 | $4.51 | +631.71% | 14 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $32 → $30 | $2.54 | +1,081.10% | 5 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $9 | $0.89 | +914.66% | 10 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $22 | $6.62 | +232.33% | 10 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $12 | $0.94 | +1,183.15% | 11 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $4 | $0.82 | +386.32% | 6 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $6 | $2.49 | +140.96% | 14 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $18 | $2.50 | +620.00% | 14 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $20 | $15.06 | +32.80% | 3 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $65 | $19.27 | +237.31% | 7 | Oct 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $6 | $1.25 | +380.00% | 10 | Sep 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 | $1.18 | +580.85% | 4 | Sep 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $3.74 | - | 1 | Apr 25, 2024 |
Imunon
Dec 19, 2024
Reiterates: Buy
Price Target: $12
Current: $1.02
Upside: +1,076.47%
TransCode Therapeutics
Dec 18, 2024
Maintains: Buy
Price Target: $3 → $20
Current: $3.64
Upside: +449.45%
Atossa Therapeutics
Dec 13, 2024
Reiterates: Buy
Price Target: $7
Current: $1.01
Upside: +593.07%
BriaCell Therapeutics
Dec 12, 2024
Reiterates: Buy
Price Target: $15
Current: $0.64
Upside: +2,241.19%
Olema Pharmaceuticals
Dec 12, 2024
Reiterates: Buy
Price Target: n/a
Current: $5.89
Upside: -
AnaptysBio
Dec 11, 2024
Downgrades: Neutral
Price Target: n/a
Current: $14.60
Upside: -
Acelyrin
Dec 11, 2024
Reiterates: Neutral
Price Target: $8
Current: $3.82
Upside: +109.42%
Arcellx
Dec 10, 2024
Reiterates: Buy
Price Target: $115
Current: $79.13
Upside: +45.33%
Geron
Dec 10, 2024
Reiterates: Buy
Price Target: $9
Current: $3.57
Upside: +152.10%
Agenus
Dec 5, 2024
Reiterates: Neutral
Price Target: n/a
Current: $3.27
Upside: -
Dec 3, 2024
Reiterates: Buy
Price Target: $12
Current: $1.12
Upside: +971.43%
Dec 3, 2024
Maintains: Buy
Price Target: $30 → $38
Current: $30.19
Upside: +25.87%
Nov 27, 2024
Reiterates: Buy
Price Target: $8
Current: $1.71
Upside: +367.84%
Nov 15, 2024
Reiterates: Buy
Price Target: $33
Current: $4.51
Upside: +631.71%
Nov 15, 2024
Maintains: Buy
Price Target: $32 → $30
Current: $2.54
Upside: +1,081.10%
Nov 15, 2024
Reiterates: Buy
Price Target: $9
Current: $0.89
Upside: +914.66%
Nov 14, 2024
Reiterates: Buy
Price Target: $22
Current: $6.62
Upside: +232.33%
Nov 12, 2024
Reiterates: Buy
Price Target: $12
Current: $0.94
Upside: +1,183.15%
Nov 11, 2024
Maintains: Buy
Price Target: $8 → $4
Current: $0.82
Upside: +386.32%
Nov 11, 2024
Reiterates: Neutral
Price Target: $6
Current: $2.49
Upside: +140.96%
Nov 11, 2024
Maintains: Buy
Price Target: $22 → $18
Current: $2.50
Upside: +620.00%
Nov 6, 2024
Reiterates: Neutral
Price Target: $20
Current: $15.06
Upside: +32.80%
Oct 24, 2024
Reiterates: Buy
Price Target: $65
Current: $19.27
Upside: +237.31%
Sep 23, 2024
Reiterates: Buy
Price Target: $6
Current: $1.25
Upside: +380.00%
Sep 6, 2024
Reiterates: Buy
Price Target: $8
Current: $1.18
Upside: +580.85%
Apr 25, 2024
Reiterates: Neutral
Price Target: n/a
Current: $3.74
Upside: -